The introduction of the Retatru vial signifies a notable breakthrough in the approach to weight regulation. This novel medication combines dual mechanisms – stimulation of the GLP-1 target and reduction of the DPP-4 enzyme – suggesting a distinctive technique for addressing obesity . Early clinical data suggest substantial efficacy in facilitat